期刊文献+

醋酸环丙孕酮有关物质和含量测定方法研究 被引量:1

Study on determination methods of related substances and contents of cyproterone acetate
下载PDF
导出
摘要 目的:优化现行醋酸环丙孕酮质量标准中有关物质和含量测定方法,以增强其质量的可控性。方法:采用高效液相色谱法,Phenomenex C 18 色谱柱(150 mm×4.6 mm,3 μm),以乙腈-水(45∶55)为流动相,检测波长为254 nm,柱温为40 ℃,进样体积为20 μl。结果:本法可用于测定醋酸环丙孕酮中的6种已知杂质和其他未知杂质;醋酸环丙孕酮含量测定线性范围为0.05~0.40 mg/ml( n=7, r =0.999 9),精密度和重复性良好。结论:优化后的方法简便,结果准确可靠,可更为有效地控制醋酸环丙孕酮的质量。 Objective: In order to enhance the controllability of cyproterone acetate quality, we optimized the current methods of the related substances and content determination in the quality standard. Method: The related substances and content determination was detected by high performance liquid chromatography(HPLC) method by using Phenomenex C18 column(150 mm×4.6 mm,3 μm), column temperature of 40 ℃, with acetonitrile-water(45∶55) as mobile phase. The detection wavelength was set at 254 nm, and the injection volume was 20 μl. Results: This method can be used to determine six known impurities and other unknown impurities in cyproterone acetate. The calibration curve of cyproterone acetate was linear in the range of 0.05~0.40 mg/ml(n=7, r=0.999 9) with good precision and repeatability. Conclusions: This optimized method is applicable, accurate and reliable for the quality control of cyproterone acetate.
作者 安彦 王卫 An Yan;Wang Wei(Tianjin Institute for Drug Control,Tianjin 300070)
出处 《天津药学》 2019年第3期5-8,共4页 Tianjin Pharmacy
关键词 醋酸环丙孕酮 高效液相色谱 有关物质 含量测定 cyproterone acetate HPLC related substances content determination
  • 相关文献

参考文献7

二级参考文献49

  • 1胡卫红,张文,吴水仙.复方醋酸环丙孕酮片的HPLC测定[J].中国医药工业杂志,2004,35(6):354-355. 被引量:5
  • 2胡家炽,黎巧明.复方醋酸环丙孕酮片的溶出度测定[J].广东药学院学报,2004,20(6):602-604. 被引量:2
  • 3Segall A, Vitale M, Perez V, et al. A stability-indicating HPLC method to determine cyproterone acetate in tablet formulations[J]. Drug Dev Ind Pharm, 2000, 26 (8): 867-872.
  • 4Scott JC, Soltero RA. HPLC method for the analysis of cyproterone acetate in tablets [J]. J Chromatogr Sci, 1987, 25 (9):415-417.
  • 5Huber J, Zeillinger R, Schmidt J, et al. Pharmacokinetics of cyproterone acetate and its main metabolite 15 beta-hydroxycyproterone acetate in young healthy women [J]. Int J Clin Pharmacol Ther Toxicol, 1988, 26 (11): 555-561.
  • 6CHENXin—qian(陈新谦) JINYou—yu(金有豫).Ⅺn Bian Yao Wu Xue(新编药物学) 14th ed(第14版)[M].Beijing(北京):People’s Medical Publishing House(,1999.441.
  • 7Geller J, Vazakas G, Fruchtman B, et al. The effect of cyproterone acetare on advanced carcinoma of the prostate. Surg Gynecol Obstet,1968,127:748.
  • 8Hammerstein J, Meckies J, Leo - Rossberg I. Use of cyproterone acetare(CPA) in the treatment of ache, hirsutism and virirism. J Steroid Biochem , 1975,6:827.
  • 9Giuliani L, Peseatore D, Giberti C, et al. Treatment of advanced prostatic carcinoma with cyproterone acetate and orchiectomy - 5 - year follow - up. Eur Urol, 1980,6 : 145.
  • 10Hammemtein J, Moltz L, Schwartz U. Antiandrogens in the treatment of acne and hirsutism. J Steroid Biochem, 1983,19:591.

共引文献44

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部